Medscape has launched a new education program for providers seeking to enhance their knowledge of gene therapy for hemophilia. “Clinical Advances in Gene Therapy for Hemophilia,” is presented through a collaboration between Medscape, the National Hemophilia Foundation, the European Haemophilia Consortium and the World Federation of Hemophilia. The program is supported by an independent educational grant from BioMarin.
Upcoming activities will include important information on the science behind gene therapy for hemophilia, the latest safety and efficacy data from clinical trials, and the potential role for gene therapy in addressing the challenges of current treatment methods.
“Test Your Knowledge of Gene Therapy for Hemophilia,” is the first activity to become available in the new series. It is intended for hematologists, pediatricians, and other healthcare professionals who manage patients with hemophilia.
Upon completion, participants will have increased knowledge regarding:
- Research on gene therapy in hemophilia
- New findings from clinical trials on gene therapy in hemophilia
Test Your Knowledge of Gene Therapy for Hemophilia
John Pasi, MB ChB, PhD, FRCP, FRCPath, FRCPCH
CME / ABIM MOC Released: 5/3/2018; Valid for credit through: 5/3/2019
If you are already registered with Medscape follow this link to “Test Your Knowledge of Gene Therapy for Hemophilia.”
Access this link to visit the “Clinical Advances in Gene Therapy for Hemophilia” homepage.
If you are not already registered, simply go to Medscape.org where registration is straightforward and free of charge.
